FDA Holds Marketers Responsible For Manufacturers’ GMP Violations
This article was originally published in The Tan Sheet
Executive Summary
FDA has begun holding own-label dietary supplement marketers responsible for their contract manufacturers’ violations of good manufacturing practices.
You may also be interested in...
Industry Roundup: GMP Warning, MedGen/Alternaturals Merger
FDA finds chaos at Chaotic Labz; investor facilitates MedGen, Alternaturals combination; more news in brief.
Industry Roundup: GMP Warning, MedGen/Alternaturals Merger
FDA finds chaos at Chaotic Labz; investor facilitates MedGen, Alternaturals combination; more news in brief.
ForMor Challenges FDA On Own-Label Supplement GMP Stance
ForMor contests a warning letter from FDA stating that as an own-label distributor, the firm is subject to both packager and labeler GMP requirements. The firm says it is only a “holder” of finished products and FDA bases its warning on the GMP rule preamble, not the actual rule.